Butcher's Broom
Best-in-class: Butcher's Broom
A vein-toning herb used for circulation, leg swelling and venous insufficiency — often stacked with diosmin/horse chestnut.
Butcher's Broom quick facts
| Suggested dose | As directed (standardized to ruscogenins). |
| How often | Daily |
| Who it's for | Circulation, leg swelling and venous support. |
Trial evidence supports it for chronic venous insufficiency, usually in combination with hesperidin and vitamin C, which is how it is typically sold. Because the mechanism is adrenergic, it can raise blood pressure and is a poor choice for anyone with hypertension or on an alpha-blocker. Less well-studied alone than diosmin.
How Butcher's Broom actually works
Ruscogenins act as alpha-adrenergic agonists on venous smooth muscle, increasing venous tone directly — a different mechanism from the flavonoids, which work mainly on permeability. That makes it complementary rather than duplicative, and it is why the two classes are often combined.
Where to get Butcher's Broom
Find Butcher's Broom on iHerb →The evidence for Butcher's Broom
Graded by what exists behind each claim.
✅ Clinically validated
- RCTs support reduced leg swelling and improved venous-insufficiency symptoms.
- Vasoconstrictive/venotonic action.
📊 Correlative data
- Traditional European use for venous and hemorrhoidal complaints, and used clinically in France and Germany for the same indication. Consistent direction across tradition and practice.
🧪 Theoretical / extrapolated benefits
- Stacks well with other venotonics for stubborn venous issues.
How to read these tiers: they say how much human evidence exists, not how well something works — and ✗ flags harm, never a disappointing trial. How the evidence tiers work →
What Butcher's Broom actually does
Butcher's broom is the only venotonic on this site with a receptor rather than an atmosphere, and the receptor is adrenergic. Ruscus aculeatus rhizome carries steroidal saponins whose aglycones are ruscogenin and neoruscogenin, and the extract acts on postjunctional alpha-1 and alpha-2 adrenoceptors on venous smooth muscle. In isolated canine saphenous vein the constrictor response to Ruscus extract was blocked in a way that separated cleanly under prazosin, an alpha-1 antagonist, and rauwolscine, an alpha-2 antagonist — which is how you demonstrate that a plant extract is working through two named receptor subtypes rather than through a generic irritant effect Rubanyi 1984.
And then the finding that should be on the front of the bottle. The response is temperature-dependent. In that same preparation, cooling the vein to 24 °C inhibited the response and warming it to 41 °C augmented the venoconstriction Rubanyi 1984. Postjunctional alpha-2 adrenoceptor coupling in cutaneous and superficial veins is known to be temperature-sensitive, and this extract inherits that sensitivity. The clinical translation is direct and nobody prints it: heavy legs are worse in hot weather because superficial veins dilate, and this is a drug whose mechanism gets stronger as the leg gets warmer. That predicts a summer effect larger than a winter effect — a seasonal dose-response that no clinical trial has ever tested for.
The second arm is the capillary, and it is a different target again. Chronic venous disease is not simply a pressure problem: sustained venous hypertension slows flow in the postcapillary venules, leukocytes roll, adhere and are trapped, and the proteases and free radicals they release degrade the capillary basement membrane, which is what produces the leak, the edema and eventually lipodermatosclerosis and the ulcer Allaert 2016. Ruscus saponins reduce capillary hyperpermeability in that setting. A venoconstrictor and a permeability agent do different jobs: one raises the venous return pressure gradient, the other stops the fluid leaving in the first place, and this plant is credited with both.
Why an alpha-agonist is a sensible thing to swallow for a leg. Venous smooth muscle carries the alpha receptors; venous capacitance is where two thirds of the blood volume sits. Constricting the capacitance vessels shifts volume centrally and reduces pooling. The same mechanism has been proposed, deliberately, in the opposite clinical direction — as a treatment for orthostatic hypotension Redman 2000. That is the cleanest possible confirmation that the effect is real and systemic: the same action that empties a swollen leg is the action that stops a fainting one.
Cell, rodent, human — and where it stops
In tissue. Isolated canine saphenous vein rings, extract applied directly to the bath, with alpha-1 and alpha-2 antagonists used to dissect the response and temperature varied across 24–41 °C Rubanyi 1984. This is an ex vivo preparation with a known concentration at the tissue — the one thing an oral capsule cannot promise.
In animals. Microvascular permeability models, extract given locally or systemically, reading protein leak and vessel diameter Allaert 2016. The route is the problem: an extract applied to a vessel and an extract eaten are separated by an absorption step that for steroidal saponins is poor and largely uncharacterized.
In people, at genuinely unusual scale. The meta-analysis covers 20 placebo-controlled randomized trials, 5 comparator studies and 6 open studies, totaling 10,246 subjects with chronic venous insufficiency. Against placebo it reports reductions in pain (0.44 points), cramps (0.26), heaviness (0.53) and paraesthesia (0.29) on symptom scales, and a fall in ankle circumference of 1.17 ± 0.83 cm Boyle 2003. Ten thousand patients is more than most prescription venoactive drugs carry.
The specific obstacle: every one of those patients took three drugs. The trials are of Cyclo 3 Fort, a fixed combination of Ruscus aculeatus extract 150 mg, hesperidin methyl chalcone 150 mg and ascorbic acid 100 mg Boyle 2003Allaert 2016. The 1.17 cm belongs to that triple. There is no comparably powered trial of Ruscus alone, which means the honest statement is that butcher's broom is a component of a well-evidenced product rather than a well-evidenced product.
And the symptom-score arithmetic deserves a second look. A 0.53-point improvement in heaviness on a scale that typically runs 0 to 3 is real and reproducible across 10,246 people, and it is also modest — roughly a sixth of the scale. Compare it with the micronized diosmin–hesperidin fraction, where heaviness carries a relative risk of 0.35 and a number-needed-to-treat of 2.0 Kakkos 2018. Both are worth having. Neither empties a leg.
Butcher's Broom — which form, and does it matter
Standardized to ruscogenins is the only label claim worth reading, and it is not enough on its own. Ruscogenin and neoruscogenin are the aglycones; the plant contains them mostly as spirostanol and furostanol glycosides, and a total-ruscogenin figure is generated after acid hydrolysis of the extract. Two products with the same ruscogenin percentage can carry very different glycoside profiles, and the glycoside is what you actually swallow.
The dose in the evidence is 150 mg of Ruscus extract per unit, inside a combination, taken two or three times a day. Boyle 2003 That is a concrete number, and it is more useful than this site's own card, which gives a standardization marker but no dose. A standalone butcher's broom capsule of 100 mg with no hesperidin methyl chalcone and no ascorbate is not the studied product and should not be expected to reproduce the studied result.
Hesperidin methyl chalcone is not hesperidin, and ascorbic acid is not filler. The chalcone is a synthetic water-soluble derivative chosen for solubility Allaert 2016; the ascorbate is there because collagen cross-linking in the vessel wall is ascorbate-dependent, which is a structural rationale rather than an antioxidant one. Anybody assembling this stack from separate bottles should know that substituting plain hesperidin for the methyl chalcone changes one of the three components.
Rhizome, not the whole plant, and not the berries. The saponins are concentrated in the rhizome and root. The red berries are not the medicine and are an emetic. Any product not naming the plant part is a product that has not read its own literature.
What would have to be true, and how you would know it was not
1. Ankle circumference down about 1 cm at four to eight weeks. That is the published effect size across 10,246 people Boyle 2003. Measure it the way the trials do: a tape at a marked height above the medial malleolus, same leg, same time each evening, seven readings averaged, before and after. The window is set by the mechanism — a venoconstrictor and permeability agent works on fluid balance, and interstitial fluid redistributes over days to weeks, not months. If nothing has moved by eight weeks it is not going to.
2. The evening-morning gap should narrow before the absolute number falls. Venous edema accumulates through the day and resolves overnight, so the sensitive read-out is the difference between a morning and an evening measurement in the same person on the same day. Predict that gap shrinks first, because it is the orthostatic component and it is the component an alpha-adrenergic venoconstrictor is mechanistically able to touch Rubanyi 1984.
3. A seasonal prediction nobody has tested. Because the venoconstrictor response is augmented at 41 °C and inhibited at 24 °C Rubanyi 1984, predict that the same dose produces a larger measured effect in a warm limb than a cool one. Practically: run your own before-and-after in the same season, and expect a July result to overstate a January one.
4. The prediction that cuts against the product. Visible varicose veins will not change. Nothing in this mechanism removes a dilated, incompetent superficial vein with failed valves; the symptom scores move and the anatomy does not Boyle 2003. Predict photographs at week 12 are indistinguishable from photographs at week 0, and treat any product marketed on the appearance of the veins as making a claim its own evidence base does not support.
What will fool you: compression stockings, a hot summer, and a fortnight of desk work versus a fortnight of walking each move ankle circumference by more than 1 cm. Change one thing.
What nobody has tested yet
Nobody has run Ruscus alone against the triple combination. Ten thousand patients of evidence and not one adequately powered three-arm trial — Ruscus 150 mg alone, hesperidin methyl chalcone 150 mg alone, and the fixed combination Boyle 2003Allaert 2016. Twelve weeks, ankle circumference as the primary endpoint. Until that exists, every standalone butcher's broom product on the shelf is being sold on somebody else's data.
The temperature experiment has never been done in a person. It is a within-subject design of almost embarrassing simplicity: same dose, same participant, plethysmography of the calf with the limb warmed and again with it cooled, before and during treatment. The ex vivo prediction is unambiguous Rubanyi 1984. Confirming it would turn a seasonal annoyance into a dosing instruction; refuting it would say the isolated-vein result does not survive an oral route.
The pharmacokinetics are effectively unpublished. No plasma concentration–time curve for ruscogenin after an oral dose of a standardized extract in humans is in general circulation, which means nobody can say whether the receptor concentrations that produced constriction in a tissue bath are ever reached in a living vein. Every mechanism sentence on this page — including the ones above — is waiting on that curve.
And nobody has tested it in the population that would benefit most. Long-haul flight and long-shift standing are the two commonest causes of the symptom this plant treats, and there is no trial of butcher's broom for flight-associated leg edema, which is a measurable, self-limiting, easily randomized model that would take one airline and two hundred volunteers.
Butcher's Broom — its own safety story, not its category's
This is a vasoconstrictor. That is not a caution imported from a category — it is the mechanism, demonstrated at named receptors Rubanyi 1984. Everything below follows from it, and it is the reason butcher's broom does not belong in the same mental box as an inert flavonoid.
Alpha-blockers: direct pharmacological opposition. Doxazosin, terazosin, tamsulosin and alfuzosin exist to block the alpha-1 receptor. This extract acts on it Rubanyi 1984. Taking both is not a vague interaction, it is an agonist and an antagonist at the same site, and the two most likely outcomes are that the supplement does nothing or that the prescription does less. If you take an alpha-blocker for prostate symptoms or for blood pressure, this is the venotonic to skip.
Blood pressure, and be specific about who. An alpha-agonist raises peripheral resistance. The published therapeutic use of that property is deliberate, in orthostatic hypotension Redman 2000 — which means the pressor effect is real enough to be exploited. If your blood pressure is uncontrolled, measure it at home before and two weeks into a course rather than assuming a herb is too weak to matter. If you have orthostatic hypotension, this is the one item in the category with a reason to help.
MAOIs, and the reason is a real pharmacology and not a boilerplate. Monoamine oxidase inhibitors raise circulating and synaptic sympathomimetic amine availability. Adding a direct alpha-adrenergic agent on top is the same class of stacking that makes decongestants a problem on an MAOI. Phenelzine, tranylcypromine, moclobemide and selegiline all belong in this sentence.
Do not treat one swollen leg with this. Unilateral swelling with calf tenderness is a deep vein thrombosis until imaging says otherwise, and an agent that reduces the symptoms of venous congestion Boyle 2003 can quiet the exact signal that should send you to a scan. Bilateral, gradual, worse at the end of the day, better after a night flat — that is the pattern this product is for.
Nausea and gastric upset are the usual reports and are the saponin acting as a mucosal irritant, which is why it is taken with food. Pregnancy and breastfeeding are unstudied here in the specific sense that matters: an alpha-adrenergic agent with an unmeasured effect on uterine and placental vascular tone has not been characterized, and that is a mechanistic reason for caution rather than a legal one.
Sources read for this page
- Rubanyi G, et al. Effect of temperature on the responsiveness of cutaneous veins to the extract of Ruscus aculeatus.. General Pharmacology 1984 · PMID 6150876
- Boyle P, et al. Meta-analysis of clinical trials of Cyclo 3 Fort in the treatment of chronic venous insufficiency.. International Angiology 2003 · PMID 14612852
- Redman DA. Ruscus aculeatus (butcher's broom) as a potential treatment for orthostatic hypotension, with a case report.. Journal of Alternative and Complementary Medicine 2000 · PMID 11152059
- Allaert FA. Combination of Ruscus aculeatus extract, hesperidin methyl chalcone and ascorbic acid: a comprehensive review of their pharmacological and clinical effects and of the pathophysiology of chronic venous disease.. International Angiology 2016 · PMID 26928296
- Kakkos SK, et al. Efficacy of micronized purified flavonoid fraction (Daflon) on improving individual symptoms, signs and quality of life in patients with chronic venous disease: a systematic review and meta-analysis of randomized double-blind placebo-controlled trials.. International Angiology 2018 · PMID 29385792
How you would know if it worked
There is no blood test for this one. That is not a criticism — it is a fact about the effect, and it changes how you should judge it.
- What to watch: Ankle circumference measured with a tape at the same marked point, last thing in the evening when swelling is at its worst, and the hour of the day at which heaviness starts. Leg volume is the endpoint this class of herb is trialed on, and it is the only thing here you can put a number to. Measure it to the nearest 5 mm at the same hour each evening.
- How long before it means anything: 8-12 weeks of continuous dosing. Take the baseline measurements for 14 days before the first capsule. Venotonic effects on edema build over weeks, and evening swelling varies enough day to day that a single before and after comparison is noise rather than a result.
- What will fool you: Almost nobody takes this one alone. It is sold to be stacked with diosmin and horse chestnut, and 3 venotonics started together cannot tell you which of them did anything or whether any of them did. Heat, standing hours, salt and long flights move leg swelling harder than any capsule in this category, so a cool week at a desk flatters it.
Run it one variable at a time. Starting three things in one week means a result you cannot attribute, which is the same as no result.
Butcher's Broom — safety & side effects
- GI upset and nausea are the usual reports.
- Mild vasoconstrictor activity — caution with hypertension, and with MAOIs and alpha-blockers.
The same on every page it applies to. Read it here; it is not repeated research.
- Not established as safe in pregnancy or breastfeeding — not because harm is documented, but because these are the two populations systematically excluded from the trials. Absence of data is not reassurance.
Not medical advice. If you take prescription medication or have a diagnosed condition, check this against it with a pharmacist or doctor — pharmacists are underused and free.
- When to take it, and what to take it with
- Which form actually absorbs
- Who it's worth it for
- Best-in-class brand pick
- Coach Cam's stacks and notes
- Fasted or with food, and when in the day
- Morning or night, and why that window
- Around training, or deliberately away from it
- What it must not share a window with
Everything above is free and stays free. Skool is where it becomes a plan — Butcher's Broom in an order, with the rest of what you're running.
Unlock in Skool — $10/mo →Bloodwork to run alongside Butcher's Broom
Baseline first, then again at 8–12 weeks.
| Marker | What it’s watching for |
|---|---|
| ApoB (Apolipoprotein B) | Counts the particles that cause plaque — a normal LDL-C can hide risk |
| Lipoprotein(a) — Lp(a) | Genetic, largely unmodifiable, and worth knowing once in your life |
| hs-CRP (High-Sensitivity C-Reactive Protein) | The inflammatory half of cardiovascular risk |
| Lipid Panel (Cholesterol, HDL, LDL, Triglycerides) | The standard baseline these are usually aimed at |
The Real Cardiovascular Risk panel covers these in one order — 9 markers, $187.60 with the discount applied.
Check results you already have → · All 103 markers A–Z
Butcher's Broom — frequently asked questions
What is Butcher's Broom?
A vein-toning herb used for circulation, leg swelling and venous insufficiency — often stacked with diosmin/horse chestnut.
What is the suggested dose of Butcher's Broom?
As directed (standardized to ruscogenins). This is a general reference for education only — statements have not been evaluated by the FDA and this is not medical advice.
Where can I find Butcher's Broom dosing and the full breakdown?
The suggested dose and the full evidence — clinical, correlative and theoretical — are on this page. What's inside Skool is when to take it, which form actually absorbs, the brand worth buying and Coach Cam's stacks.
Where can I buy Butcher's Broom?
Coach Cam sources Butcher's Broom from vetted, top-rated brands on iHerb — use the buy link on this page.
Butcher's Broom inside a finished plan
One arm of 1 Protocol Blueprint, free to read in full.
What Butcher's Broom is used for
Butcher's Broom appears under 1 goal in the goal router.
Related Cardiovascular supplements
Where this goes next
Butcher's Broom is the venous arm of this plan. The page above is the free breakdown of one compound; the plan it belongs to — the dosing, the order to correct things in, the week-by-week schedule and what to retest — is a lesson inside Skool.